Nephrotoxicity in the elderly due to co-prescription of ACE inhibitors and NSAIDs [5]

Journal of the Royal Society of Medicine

Volumn 94, Issue 12, 2001, Pages 657-658

  Jolobe, O M P ^a  

^a TAMESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; SPIRONOLACTONE;

DRUG MECHANISM; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; NEPHROTOXICITY; PRESCRIPTION;

EID: 0035217968     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107680109401228     Document Type: Letter

References (7)

1. Evaluation of renal function in elderly heart failure patients on ACE inhibitors
2. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
3. Serious adverse events experienced by patients with chronic heart failure taking spironolactone
4. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: An analysis of 25 cases
5. Indomethacin-induced prostaglandin inhibition with hyperkalemia: A reversible cause of hyporeninemic hypoaldosteronism
6. Acute renal failure with rofecoxib
7. Selective cyclooxygenase-2 inhibitors: A pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs